Postoperative hyperprolactinaemia and early recurrence rate in breast cancer.
Serum levels of prolactin before and after surgery were measured in 90 women with breast cancer until the 5th postoperative month. Surgery-induced hyperprolactinaemia occurred in 51 patients, without significant correlation to any other clinical variable. After a median follow-up of 39 months, irrespective of each other variable (i.e. nodal involvement, oestrogen receptor status, adjuvant therapies), patients with postoperative hyperprolactinaemia had a significantly lower recurrence rate than those in whom surgery was not followed by an abnormal increase in prolactin secretion (3/51 vs. 13/39, P less than 0.001). These results suggest that, despite the stimulatory role of prolactin on mammary tumours, the lack of postoperative hyperprolactinaemia is an unfavourable prognostic factor because of its association with a higher relapse rate.
Lissoni
P
P
Division of Radiation Oncology, San Gerardo Hospital, Italy.
Sormani
A L
AL
Tancini
G
G
Cattaneo
G
G
Archili
C
C
Mandelli
D
D
Crispino
S
S
Paolorossi
F
F
Barni
S
S
D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000097:blood*; D005260:Female; D006801:Humans; D006966:Hyperprolactinemia / Q000209:etiology; D008875:Middle Aged; D011379:Prognosis; D011388:Prolactin / Q000097:blood*; D012008:Recurrence; D013997:Time Factors
D011388:Prolactin